(0.32%) 5 034.46 points
(0.39%) 38 051 points
(0.55%) 15 691 points
(-0.08%) $78.94
(3.78%) $2.01
(-0.25%) $2 305.30
(0.29%) $26.83
(0.48%) $959.45
(0.28%) $0.936
(0.37%) $11.07
(0.30%) $0.801
(-1.37%) $91.98
Live Chart Being Loaded With Signals
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy...
Stats | |
---|---|
Šios dienos apimtis | 45 071.00 |
Vidutinė apimtis | 195 431 |
Rinkos kapitalizacija | 39.28M |
EPS | $0.0500 ( 2024-03-12 ) |
Kita pelno data | ( $-0.0600 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.48 |
ATR14 | $0.0150 (1.01%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Wood Susan Alyson | Buy | 13 044 | Director Stock Option (right to buy) |
2024-04-01 | Patel Rakesh | Buy | 22 154 | Director Stock Option (right to buy) |
2024-04-01 | Doyle Michael John | Buy | 9 874 | Director Stock Option (right to buy) |
2024-04-01 | Hricak Hedvig | Buy | 5 415 | Director Stock Option (right to buy) |
2024-04-01 | Sassine Andy | Buy | 25 259 | Director Stock Option (right to buy) |
INSIDER POWER |
---|
95.97 |
Last 93 transactions |
Buy: 2 731 076 | Sell: 491 820 |
Tūris Koreliacija
ICAD Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
RCON | 0.819 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
LHCG | -0.819 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
ICAD Inc Koreliacija - Valiuta/Žaliavos
ICAD Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $17.32M |
Bruto pelnas: | $14.54M (83.94 %) |
EPS: | $-0.290 |
FY | 2023 |
Pajamos: | $17.32M |
Bruto pelnas: | $14.54M (83.94 %) |
EPS: | $-0.290 |
FY | 2022 |
Pajamos: | $27.94M |
Bruto pelnas: | $19.81M (70.90 %) |
EPS: | $-0.540 |
FY | 2021 |
Pajamos: | $33.64M |
Bruto pelnas: | $24.24M (72.07 %) |
EPS: | $-0.450 |
Financial Reports:
No articles found.
ICAD Inc
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.